Recorded fact · drug.label_indication
drug.label_indication for belimumab|lupus
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 45ddaecd resolves to.
The record
| Fact id | 45ddaecd9eb247fe5fe4185d |
|---|---|
| Entity | drug: belimumab|lupus |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260821 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Active systemic lupus erythematosus (SLE) who are receiving standard therapy, and • Active lupus nephritis who are receiving standard therapy.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 003e0235e2f9a294ae295841800b9c38cf204c507355173488914d556948fa62.
The value
{
"ingredient": "Belimumab",
"conditionId": "lupus",
"conditionName": "Lupus",
"matchedAlias": "lupus",
"context": "indication",
"brand": "BENLYSTA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "2fa3c528-1777-4628-8a55-a69dae2381a3",
"labelEffectiveTime": "20260821",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: fcdfc153a94cfa586cb3e65a05f56bfde5d4648180150fee08475dbe7590e16e.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.